New study tracks hidden risks of hepatitis b drugs in vulnerable patients
Knowledge-focused
Recruiting now
This study follows 490 adults with a past hepatitis B infection who need immune-suppressing treatments. Researchers will monitor bone, kidney, and metabolic health over 4 years to understand the long-term side effects of antiviral drugs. The goal is to create better safety guidel…
Sponsor: Yaşar Bayındır, MD • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC